Journal: World Journal of Gastrointestinal Oncology
Article Title: Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma
doi: 10.4251/wjgo.v12.i3.276
Figure Lengend Snippet: Differential expression of KIF21B in The Cancer Genome Atlas database and hepatocellular carcinoma cell lines. A and B: Differential expression levels of KIF21B in 50 pairs of matched hepatocellular carcinoma and adjacent normal tissues from the The Cancer Genome Atlas database ( P < 0.01); C: KIF21B expression was examined in BEL-7404, BEL-7402, Hep-G2, SMMC-7721, and Chang liver cells. All the data were normalized to mRNA expression levels of human GAPDH using the 2 -ΔΔCT method. All the experiments were conducted in triplicate. Data were analyzed by ANOVA or t -test. The data are reported as the mean ± SD. P < 0.05 was considered significant, a P < 0.05, b P < 0.01.
Article Snippet: HCC cell lines Hep-G2, BEL7402, BEL-7404, and SMMC-7721 and the normal liver cell line Chang liver were purchased from Shanghai Genechem Co., Ltd. (Shanghai, China).
Techniques: Quantitative Proteomics, Expressing